Stocks and Investing Stocks and Investing
Wed, April 19, 2023

Nathan Rich Maintained (ALHC) at Strong Buy with Decreased Target to $12 on, Apr 19th, 2023


Published on 2024-10-28 02:52:37 - WOPRAI, Nathan Rich
  Print publication without navigation


Nathan Rich of Goldman Sachs, Maintained "Alignment Healthcare, Inc." (ALHC) at Strong Buy with Decreased Target from $14 to $12 on, Apr 19th, 2023.

Nathan has made no other calls on ALHC in the last 4 months.



There are 3 other peers that have a rating on ALHC. Out of the 3 peers that are also analyzing ALHC, 1 agrees with Nathan's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Lisa Gill of "JP Morgan" Downgraded from Buy to Hold and Decreased Target to $12 on, Thursday, February 23rd, 2023


These are the ratings of the 2 analyists that currently disagree with Nathan


  • Jessica Tassan of "Piper Sandler" Maintained at Buy with Decreased Target to $12 on, Friday, March 3rd, 2023
  • Gary Taylor of "TD Cowen" Maintained at Buy with Decreased Target to $10 on, Thursday, March 2nd, 2023

Contributing Sources